Publications

Quick Research

Filters Clear All

Any Time

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Country

Argentina
Australia
Austria
Bangladesh
Barbados
Belarus
Belgium
Brazil
Bulgaria
Burkina Faso
Cambodia
Cameroon
Canada
Chile
China
Chinese Taiwan
Croatia
Cyprus
Czech
Czechia
Denmark
Egypt
Estonia
Ethiopia
Finland
France
Gabon
Germany
Ghana
Greece
Guyana
Hungary
India
Iran
Ireland
Israel
Italy
Japan
Kenya
Korea
Kuwait
Luxembourg
Madagascar
Malaysia
Mexico
Mongolia
Morocco
Mozambique
Myanmar
Nepal
Netherlands
New Zealand
Niger
Nigeria
Norway
Pakistan
Philippines
Poland
Portugal
Romania
Russia
Russian Federation
Saudi Arabia
Singapore
Slovenia
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Thailand
Tunisia
Turkey
UAE
UK
USA
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vietnam

Procell has assisted our customers in publishing 26,002 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.

Filter

2023

OSU-03012 Disrupts Akt Signaling and Prevents Endometrial Carcinoma Progression in vitro and in vivo (2021-04-30)

Journal: Drug Design Development and Therapy (2021) IF: 4.319

DOI: 10.2147/DDDT.S304128

Products Cited: McCoy's 5A Medium, KLE Cells Line, McCoy's 5A
Protective Effect of Lemon Peel Extract on Oxidative Stress in H9c2 Rat Heart Cell Injury (2021-05-14)

Journal: Drug Design Development and Therapy (2021) IF: 4.3

DOI: 10.2147/DDDT.S304624

Products Cited: H9c2(2-1) Cells Line, H9c2 (2-1) Cells Line
Study on the Inhibitory Effect of Curcumin on GBM and Its Potential Mechanism (2021-06-28)

Journal: Drug Design Development and Therapy (2021) IF: 4.319

DOI: 10.2147/DDDT.S306602

Products Cited: U251 Cells Line
Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway (2021-08-21)

Journal: Drug Design Development and Therapy (2021) IF: 4.319

DOI: 10.2147/DDDT.S317701

Products Cited: Fetal Bovine Serum, DMEM (High glucose) Medium, LX-2 Cells Line
Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways (2021-02-09)

Journal: Plos Computational Biology (2021) IF: 4.3

DOI: 10.1371/journal.pcbi.1008696

Products Cited: HCC 94 [HCC941122] Cells Line, Hep G2 Cells Line, Hep 3B2.1-7 Cells Line
Silenced lncRNA H19 and up-regulated microRNA-129 accelerates viability and restrains apoptosis of PC12 cells induced by Aβ25-35 in a cellular model of Alzheimer’s disease (2021-01-07)

Journal: Cell Cycle (2021) IF: 4.3

DOI: 10.1080/15384101.2020.1863681

Products Cited: 1 M HEPES Solution
Circular RNA circ_HECTD1 regulates cell injury after cerebral infarction by miR-27a-3p/FSTL1 axis (2021-04-12)

Journal: Cell Cycle (2021) IF: 4.3

DOI: 10.1080/15384101.2021.1909885

Products Cited: HT22 Cells Line
Hsa_circ_0008360 sponges miR-186-5p to target CCND2 to modulate high glucose-induced vascular endothelial dysfunction (2021-07-05)

Journal: Cell Cycle (2021) IF: 4.3

DOI: 10.1080/15384101.2021.1918877

Products Cited: Penicillin-Streptomycin Solution, 100×
ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway (2021-06-07)

Journal: Cell Cycle (2021) IF: 4.3

DOI: 10.1080/15384101.2021.1919828

Products Cited: HCCLM3 Cells Line, Hep 3B2.1-7 Cells Line, HuH-7 Cells Line
Circ_0017956 promotes the proliferation and metastasis of non-small cell lung cancer through regulating miR-515-5p/ITGB8 axis (2021-05-04)

Journal: Cell Cycle (2021) IF: 4.3

DOI: 10.1080/15384101.2021.1919829

Products Cited: A549/DDP Cells Line, NCI-H1299 Cells Line, HBE135-E6E7 Cells Line